-
Description
-
Why Us?
Recommended for 6 weeks or above children
(total 22 doses):
- Doctor Evaluation
- 6-in-1 vaccine - 3 doses
- Rotateq - 3 doses
- 13-valent pneumococcal conjugate vaccine (PCV13) - 4 doses
- ACWY Meningococcal Vaccine - 2 doses
- Meningococcal Group B Vaccine - 3 doses
- Japanese Encephalitis Vaccine - 2 doses
- 5 in 1 Vaccine - 1 dose
- MMRV - 2 doses
- Hepatitis A Vaccine- 2 doses
- Injection procedure is handled by Registered Doctor
Vaccination schedule
2M
- Rotateg - 1st doses
- 6-in-1 vaccine - 1st dose
- 13-valent pneumococcal conjugate vaccine (PCV13) - 1st dose
4M
- Rotateg - 2nd doses
- 6-in-1 vaccine - 2nd dose
- 13-valent pneumococcal conjugate vaccine (PCV13) - 2nd dose
6M
- Rotateg - 3rd doses
- 6-in-1 vaccine - 3nd dose
- 13-valent pneumococcal conjugate vaccine (PCV13) - 3rd dose
- Meningococcal Group B Vaccine - 1st dose
9M
- ACWY Meningococcal Vaccine - 1st dose
- Meningococcal Group B Vaccine – 2nd dose
- Japanese Encephalitis Vaccine - 1st dose
1 year old
- MMRV - 1st dose
- Hepatitis A Vaccine - 1st dose
13M
- 13-valent pneumococcal conjugate vaccine (PCV13) – 4th dose
- Meningococcal Group B Vaccine – 3rd dose
15M
- MMRV – 2nd dose
- ACWY Meningococcal Vaccine – 2nd dose
18M
- Hepatitis A Vaccine - 2nd dose
- 5 in 1 Vaccine - 1st dose
- Hepatitis A Vaccine – 2nd dose
Clearbridge Health Limited is an integrated healthcare group with a focus on the delivery of precision medicine with businesses comprising of laboratory testing services, medical centres/clinics and strategic equity participation in complementary precision medical technology companies. We are present in more than 10 countries around the world and have plans to further expand our presence in Pan Asia. Working closely with healthcare professionals and globally-accredited laboratories, Clearbridge Health offers patient care through precision diagnostics, empowers clinicians and healthcare professionals to make reliable and accurate diagnoses, providing fresh insights into disease management, customising prevention and treatment programmes that are personalised and timely. Listed on the Catalist Board of the SGX-ST, Clearbridge Health Limited Group of Companies continues to provide effective ways to detect cancer, critical illness, and other lifestyle diseases in the world today.
VISION
Redefining healthcare in Asia with precision.
Empowering patient care with clarity.
MISSION
Setting a new standard for personalized care through the integration of healthcare services, medical technology and data science.
CORE VALUES
Kindness You always come first
Confidence We believe that better outcomes start with precise insights
Dependability Our people – they are our edge
Respect Professionalism in every circumstance
Trust Delivering healthcare services with utmost integrity